baber/WOPTO huggingface dataset:
Patent NZ-534052-A (NZ)
Title: Panel systems and a connection device therefor
Inventor: LEWIS WARREN PAUL
Filed: 2004-08-13
Abstract: A panel system includes at least two panels, each panel having a hinge comprising a hinge pin, for hinged connection to a frame and a connection device for releasably connecting the hinge pins of adjacent panels together and/or connecting the hinge pin of a panel to a hinge pin provided on an edge of the frame. The arrangement and construction is such that the connection device includes adjustment means for adjusting a gap between connected panels and/or between a panel and the edge of the frame.
Patent NZ-537009-A (NZ)
Title: Drying assembly and method of drying for a flooded enclosed elevated space
Inventor: CRESSY CHARLES S
IPC: F26B23/00
Filed: 2003-07-09
Abstract: A portable hand truck mounted drying assembly for the drying of an elevated enclosed space which has been subjected to flooding, the drying assembly (10) having an inlet path for the introduction of ambient air into the enclosed space (13), the ambient air being preheated in a heat exchanger (12) by moisture laden air removed from the enclosed space (13), the preheated ambient air being subjected to further heating before introduction into the enclosed space (13), the portable hand truck mounted unit being positioned within the enclosed space (13) and having a plurality of conduits (22, 24, 26, 28) in communication with the enclosed space (13) for the introduction of dry heated air and the removal of moisture laden air.
Patent NZ-542219-A (NZ)
Title: 2,4-di(phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory diseases and immune system disorders
Inventor: GARCIA-ECHEVERRIA CARLOS
IPC: A61K31/506
Filed: 2004-03-12
Abstract: Disclosed is a compound of formula I wherein the substituents are disclosed within the specification or a pharmaceutically acceptable salt thereof. Also disclosed is the use of the above compound for the manufacture of a medicament for the treatment or prevention of neoplastic diseases and immune system disorders.
Patent NZ-542640-A (NZ)
Title: Use of angiontensin II antagonists including losartan, candesartan, cilexetil, irbesartan and candesartan for the treatment or prevention of metabolic syndrome or Syndrome X
Inventor: LJUNGGREN ANDERS
IPC: A61K31/41
Filed: 2004-03-31
Abstract: Disclosed is the use of an angiotensin II type 1 receptor antagonist alone, or in combination with a metabolically neutral antihypertensive substance, for the manufacture of a medicament for the prevention and/or treatment of the metabolic syndrome.
Patent NZ-543885-A (NZ)
Title: Apparatus and method for processing service interactions
Inventor: CLORAN MICHAEL ERIC
IPC: G06Q10/00
Filed: 2004-05-05
Abstract: A method for operating an interactive response system is disclosed. The method includes: receiving data representing an utterance from a person; using a processor, automatically presenting the utterance in perceptible form to a number of intent agents at the same time, each through an agent user interface; accepting intent input from each of the number of intent agents through the respective agent user interface, where the intent input characterizes the intent agent's interpretation of the person's intent expressed in the utterance; when the number of intent agents provide intent input that characterizes different interpretations of the person's intent, then using a processor, automatically presenting the utterance in perceptible form to at least one additional intent agent through an agent user interface; and accepting further intent input from the at least one additional intent agent through the respective agent user interface, where the further intent input characterizes the at least one additional intent agent's interpretation of the person's intent expressed in the utterance; and using a processor, automatically communicating a message to the person, in perceptible form and in substantially real time relative to the receiving step, the message being selected as a function of the intent input accepted from the intent agents.
Patent NZ-549237-A (NZ)
Title: Game with 3-D representation of a geographical area, and random selectors for magnitude and mode of travel
Inventor: WICKS LEONARD CHARLES
Filed: 2006-08-16
Abstract: A geographical game is disclosed with a three-dimensional representation of a geographical area showing permitted travel routes. Two random selectors are provided for respective magnitude and travel mode. The extent of player movement is determined using the first and second selectors.
Patent NZ-549491-A (NZ)
Inventor: SOLOMON TREVOR
IPC: C09D5/16
Filed: 2005-01-19
Abstract: Disclosed is an antifouling coating composition comprising a) 20-100% by weight, calculated on the total amount of film-forming components, of a film-forming polymer (A) having an acrylic backbone bearing at least one terminal group of the formula: -X-[O-M-R]n wherein X represents -C(=O)-, -C(=S)-, -P(=O)- or -P(=O)<; M is a metal of Group Ib, IIa, IIIa, IIlb, IVa, IVb, Va, VIa, VIb, VIIa, and VIII of the Periodic Table with a valency of 2 or more and a degree of ionisation less than that of the alkali metals metal; n is an integer of 1 to 2; R represents an organic residue selected from -S-C(=S)-R1, -O-C(=O)-R1, -O-C(=S)-R1, -O-R1, -S-R1 or -O-S(=O)2-R1; and R1 is a monovalent organic residue, and b) 80-0% by weight, calculated on the total amount of film-forming components, of polymer (B) is selected from polymers which are free of -X-[O-M-R]n terminal groups but which are reactive in water, slightly water-soluble, water sensitive, or insoluble in water, and c) a copper-based biocide for aquatic organisms wherein the antifouling coating composition is substantially free of any biocidal zinc compounds and substantially free of rosin, and the copper-based biocide has a metallic copper content below 2 % by weight, based on the total weight of the copper-based biocide.
Patent NZ-552977-A (NZ)
Title: Drilling head for an anchor
Inventor: HEEMANN KAY
Filed: 2007-02-01
Abstract: A drilling head, for being secured into a hollow anchor tube, is disclosed. The drilling head (1) has hard metal cutters (2) and a drive-side axially oriented with stop shoulder (4) passing into a conical surface (5) that in use locks into a thin-walled hollow tube (3).
Patent NZ-556610-A (NZ)
Title: An implantable biomaterial and a method of producing same
Inventor: NEETHLING WILLIAM MORRIS LEONARD
IPC: A61F2/02
Filed: 2005-12-20
Abstract: Disclosed is a method for producing a calcification resistant implantable biomaterial. The disclosed method includes: (a) exposing a biomaterial to an alcohol-containing solution for at least 24 hours; (b) exposing said material in step (a) to a cross-linking agent; and (c) exposing said material in step (b) to an acidic solution; wherein step (b) and (c) are sequential to step (a). Also disclosed are biomaterials, biological devices, biocompatible implants, wound dressings and kits produced by the disclosed method.
Patent NZ-563490-A (NZ)
Title: Method for the production of polyoxymethylene dialkyl ethers from trioxane and dialkylethers
Inventor: STROFER ECKHARD
IPC: C07C41/50
Filed: 2006-06-12
Abstract: A process for preparing polyoxymethylene dialkyl ethers of formula: H2m+1CmO(CH2O)nCmH2m+1 where n is 2 to 10, m independently is 1 or 2 is disclosed, in which a dialkyl ether selected from dimethyl ether, methyl ethyl ether or diethyl ether and trioxane are fed into a reactor and reacted in the presence of an acid catalyst, whereby the amount of water introduced into the reaction mixture with the dialkyl ether, trioxane and/or the catalyst is less than 1 % by weight based on the reaction mixture.
Patent NZ-572034-A (NZ)
Title: Transmission of signaling information of broadcast and multicast services
Inventor: VAYANOS ALKINOOS HECTOR
IPC: H04J3/16
Filed: 2005-02-10
Abstract: A method in a communication system is disclosed. The method includes: transmitting signaling information for at least one service in each of a number of repetition periods of a current modification period and transmitting changes to the critical signaling information for the service starting at a next modification period. The signaling information is comprised of critical signaling information and non-critical signaling information. (62) Divided Out of 549092
Patent NZ-573701-A (NZ)
Title: Methods, systems and apparatus for monitoring and/or generating communications in a communications network
Inventor: PARSONS BRIAN
Filed: 2008-02-07
Abstract: An apparatus for generating communications to be sent to destination nodes in a communications network is provided. The apparatus includes an engine communicatively coupled to an analyser, a processor communicatively coupled to the engine and the analyser, and a database. The processor is configured to transmit control signals to the engine and/or the analyser, and the engine and the analyser are configured to: select and/or generate the destination nodes and/or source nodes from which the communications are to be sent in response to the control signals, and to generate and route communications to the destination nodes using parameters from the database.
Patent NZ-575180-A (NZ)
Title: Capsule for brewing a beverage
Inventor: OZANNE MATTHIEU
IPC: B65D85/804
Filed: 2007-08-29
Abstract: The capsule (2) for the preparation of a beverage in a beverage machine comprises : a brewing enclosure (20) containing one or more beverage ingredients; filtering means (22) delimiting at least one filtering side of the brewing enclosure, beverage flow guiding means (40) configured to guide the beverage to a beverage outlet (41b) of the capsule, a shell (21) and a protective cover (4) that is attached to the shell and forms with the shell a gas tight container for the beverage ingredients; The capsule further comprises opening means comprising an opening element (43) arranged outside the brewing enclosure and configured to open the gas-tight container in order to create the beverage outlet (41b), said gas tight container integrally housing the beverage flow guiding means (40) and the opening element (43).
Patent NZ-576999-A (NZ)
Title: Treatment of bananas and pineapples with an antifungal composition comprising a polyene antifungal agent and a phosphite containing compound
Inventor: STARK JACOBUS
IPC: A01N59/26
Filed: 2007-12-06
Abstract: A process for the treatment or prevention of crown rot resulting from harvesting of fruits selected from bananas and pineapples. The treatment comprises applying a composition comprising a polyene antifungal and at least one phosphite containing compound to the fruit. In particular the polyene is natamycin and the wound is a result of removing the fruit from the tree.
Patent NZ-578759-A (NZ)
Title: Identification device for animal with latching means comprising pin and hole arrangement
Inventor: MOUILLE STEPHANE
IPC: A01K11/00
Filed: 2008-03-06
Abstract: An animal identification tag or label (1) shaped as a band or strap that encircles the animal's limb or leg, one end of the band (2b) has a series of raised horizontal axis latching holes (8',8) that pass through aligned matching holes at the opposite end of the band (2a) to complete the ring and the two ends are securely fastened by pins (6) passing through the raised horizontal axis latching holes. The band is made from deformable plastic polymer, and can be adjusted in length by aligning the latching holes through different holes in the band. The band has space for markings or carrying an electronic transponder, and a weaker area to allow easier cutting of the band.
Patent NZ-580934-A (NZ)
Title: Devices, systems, and methods for accessing the epicardial surface of the heart
Inventor: KASSAB GHASSAN S
IPC: A61B18/18
Filed: 2008-02-05
Abstract: Devices, systems, and methods for accessing the internal and external tissues of the heart are disclosed. At least some of the embodiments disclosed herein provide access to the external surface of the heart through the pericardial space for localized delivery of leads to the heart tissue. In addition, various disclosed embodiments provide devices, systems, and methods for closing a hole in cardiac tissue.
Patent NZ-581793-A (NZ)
Title: Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
IPC: C07K/
Filed: 2002-06-18
Abstract: Provided is a molecule consisting of consecutive segments, beginning at the amino terminus of the molecule: (i) a human MHC-restricted peptide capable of eliciting a memory response when present in the molecule, (ii) a first peptide linker, (iii) a human beta-2 microglobulin, (iv) a second peptide linker, (v) a HLA-A2 chain of a human MHC class I molecule, (vi) a tumor-specific antibody targeting domain, wherein the segments (v) and (vi) are bound to each other directly by a peptide bond or by a third peptide linker, and wherein the carboxyl terminus of each of segments (i) through (v) is bound to the amino terminus of segments (ii) through (vi), respectively. Segment (i) can be a viral protein, including CMV. (62) Divided Out of 568650
Patent NZ-582495-A (NZ)
Title: Promoterless cassettes for expression of alphavirus structural proteins
Inventor: KAMRUD KURT I
IPC: C07K14/705
Filed: 2008-06-20
Abstract: Disclosed is an isolated RNA molecule comprising: a) an alphavirus 5' replication recognition sequence, wherein at least one initiation codon has been removed from the 5' replication recognition sequence; b) a nucleotide sequence encoding an alphavirus structural protein; and c) an alphavirus 3' replication recognition sequence, with the proviso that the RNA molecule does not contain a promoter that directs transcription of the nucleotide sequence of (b), and wherein the alphavirus 5' and 3' replication recognition sequences of (a) and (c) direct replication of the RNA molecule in the presence of alphavirus nonstructural proteins.
Patent NZ-585752-A (NZ)
Title: Process for the synthesis of propargylated aminoindan derivatives
Inventor: PHULL MANJINDER SINGH
IPC: C07C209/08
Filed: 2008-12-19
Abstract: Disclosed is a process for preparing N-propargyl 1-indanamine ((1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine also termed as Rasagiline) or its enantiomer, which comprises: (a) reacting racemic 1-aminoindan or its enantiomer with an allyhalide in presence of a base to give N-allyl-1-aminoindan or its enantiomer; (b) halogenating the N-allyl-1-aminoindan or its enantiomer with a halogenating agent in a suitable organic solvent to give N-(2,3 dihalo propyl)-1-aminoindan or its enantiomer; and (c) treating the N-(2,3-dihalo propyl)-1-aminoindan or its enantiomer with a suitable base to give N-propargyl 1-indanamine or its enantiomer. Also disclosed in the intermediate N-(2,3-dibromo propyl)-1-aminoindan.
Patent NZ-588634-A (NZ)
Title: Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase
Inventor: BISCHOFF ALEXANDER
IPC: H01M50/15
Filed: 2009-03-20
Abstract: Disclosed herein are piperazine derivatives of the given formula, wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as they act as inhibitors of stearoyl-CoA desaturase and are there useful in the treatment of obesity.
Patent NZ-590245-A (NZ)
Title: A portable interface device and pump
Inventor: WILCOCK PETER JOHN
IPC: A47C7/00
Filed: 2010-12-24
Abstract: Disclosed is an interface device or back support cushion for a seat or chair that van be adjusted to fit both a person’s back and the backrest of the chair. The cushion comprises an airtight receptacle or bladder, a movable filling within the airtight receptacle, a port attached to the airtight receptacle to allow the receptacle to be pressurised, vacuumed, evacuated or sealed. The interface device is formed from multiple layers each having varying flexible properties in different zones or has a shaped profile that fits between two objects substantially without creating a transition area.
Patent NZ-590372-A (NZ)
Title: Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats)
Inventor: PRIEBE WALDEMAR
IPC: A61K31/4402
Filed: 2009-06-26
Abstract: Disclosed are pyridine compounds represented by general formula (I), such as (2E,4E)-5-(6-chloropyridin-2-yl)-2-cyano-N-[ (1R)-1-phenylethyl]penta-2,4-dienamide, or pharmaceutically acceptable salts thereof. Also disclosed is the use of the compounds of formula (I) for treating cancer, proliferative angiogenic conditions, proliferative skin disorders, central nervous system diseases, inflammatory disorders, and auto-immune diseases.
Patent NZ-592099-A (NZ)
Title: Gas liquid contactor and method thereof
Inventor: COURTRIGHT JEFFREY L
IPC: B01D47/06
Filed: 2009-09-28
Abstract: 592099 Disclosed is an apparatus (100) and method of processing gas phase molecules with a gas liquid contactor. The absorption of a gas into a liquid is a key process step in a gas liquid contacting system. The apparatus (100) comprises a chamber (114). The apparatus further comprises a gas inlet (116), a gas outlet (118) and a fluid plenum coupled to the chamber (114). An individually fed nozzle bank (106) comprising more than one nozzle is coupled to the fluid plenum. Each nozzle is configured to provide an essentially planar liquid jet (124). A gas fluid separator is coupled to the chamber (114). The method comprises the steps of forming a plurality of liquid jets (124) with a plurality of individually fed nozzle banks (106) each comprising a plurality of individually fed nozzles. Providing the gas with at least one or more reactive soluble gas phase molecules and reducing a concentration of the gas phase molecules by mass transfer interaction between the gas phase molecules and the liquid jets.
Patent NZ-597551-A (NZ)
Title: Pyridine and pyrazine derivatives as protein kinase modulators
Inventor: BARSANTI PAUL A
IPC: A61K31/444
Filed: 2010-07-28
Abstract: 597551 Disclosed herein is a compound of formula (I), wherein the variables are defined in the specification; a pharmaceutical composition comprising said compound; and the use of said compound in the treatment of a disease or condition mediated by CDK9, such as cancer, cardiac hypotrophy, HIV, and inflammatory diseases. Embodiments of the compound include the following: 3,5'-dichloro-N2'-(trans-4-(((R)-2,2-dimethy-1-1,3-dioxolan-4-yl)methyl)aminocyclohexyl)-N6-((tetrahydro-2H-pyran-4-yl)methyl)-2,4'-bipyridine-2',6-diamine, and trans-4-(5-chloro-4-(6-((tetrahydro-2H-pyran-3-yl)methyl)aminopyrazin-2-yl)pyridin-2-yl-amino)cyclohexanol.
Patent NZ-598995-A (NZ)
Title: Producing edible residues from ethanol production
Inventor: MEDOFF MARSHALL
IPC: A23K10/38
Filed: 2010-10-12
Abstract: Disclosed is a method comprising irradiating edible residues, wherein the edible residues have been produced as a by-product of bioprocessing a feedstock comprising a cellulosic and/or lignocellulosic feedstock to produce a sugar.
Patent NZ-607641-A (NZ)
Title: Compact liquid container
Inventor: FARRAR PETER
IPC: B67C3/28
Filed: 2011-08-25
Abstract: The present invention relates to a container system for liquids such as spray fragrances. The system includes a parent container (110) and a child container (120). The parent container provides a first cavity (113) for confining a liquid, and couples detachably to the child container for refilling the child container through a supply opening (111) in the parent container. The child container can be used for instance as a travel pack in a handbag or hand luggage. Here the child container is a compact dispenser, comprising a bowl-shaped rigid container (221) having a refill opening, which is kept closed by a valve unless the dispenser is connected to the parent container, and a dispensing opening. These openings are located apart from each other. A pump (225) dispenses liquid from the dispense opening. In a particularly simple construction, the opening of the bowl is covered by a deformable membrane to form a closed dispense cavity, the cavity becoming mainly or completely evacuated as the dispensing means is operated. The membrane then relaxes again, filling the dispenser, when the dispenser is re-applied to the parent container.
Patent NZ-612055-A (NZ)
Title: Antitumor combinations containing antibodies recognizing specifically cd38 and bortezomib
Inventor: DECKERT JUTTA
IPC: A61P35/00
Filed: 2011-12-08
Abstract: Disclosed is a pharmaceutical combination comprising an antibody specifically recognising CD38, with the sequence ids as disclosed in the specification, and at least bortezomib, wherein the antibody is capable of killing a CD38+ cell by apoptosis, antibody-dependent cell-mediated cytotoxicity (ADCC), and complement dependent cytoxicity (CDC), and wherein the antibody comprises at least one heavy chain and at least one light chain, wherein (i) the heavy chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 1, 2, and 3, and wherein the light chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 4, 5, and 6; (ii) the heavy chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 7, 8, and 9, and wherein the light chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 10, 11, and 12; (iii) the heavy chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 13, 14 (or 81), and 15, and wherein the light chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 16, 17, and 18; (iv) the heavy chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 19, 20, and 21, and wherein the light chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 22, 23, and 24; (v) the heavy chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 25, 26, and 27, and wherein the light chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 28, 29, and 30; or (vi) the heavy chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 31, 32, and 33, and wherein the light chain comprises three sequential complementarity-determining regions having amino acid sequences represented by SEQ ID NOS: 34, 35, and 36.
Patent NZ-616436-A (NZ)
Title: Method of security screening and security tray for use therewith
Inventor: ROSS DOUGLAS ALBERT
IPC: G01N23/04
Filed: 2013-02-07
Abstract: A method for allowing security personnel in screening stations to more quickly identify prohibited articles and to identify and interrogate the screened individual responsible for the prohibited article, thereby improving throughput and reducing human error. If an operator observes articles which raise a security concern, the operator isolates the location of such articles by referencing the compartment in the tray where it is located and optionally whether the article is in a high or low position in the compartment and by referencing a tray's unique identifier. A security tray design is provided to carry out the method which includes discrete delineated compartments, and optionally a unique identifier and an area for displaying the screened individual's identification to connect the individual to a unique tray, to assist in preventing individuals from gaining access to restricted areas with prohibited articles.